PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Cellular railroad switches: how brain cells route supplies to build memories

2025-10-14
(Press-News.org) When we form a memory, brain cells need to deliver supplies to strengthen specific neural connections. A new study from MPFI and Weill Cornell Medicine has revealed how two cellular switches, Rab4 and Rab10, direct supplies to where they are needed.

 

Key Findings

New tools track cellular supply routes: Scientists created biosensors to measure Rab proteins, cellular switches that direct the delivery of supplies inside cells. Beyond the findings in this paper, these sensors allow observation of the activity along complex supply routes, critical for many cellular functions. Rab4 provides a boost in the first minutes: During the strengthening of neuronal connections, Rab4 is activated, rapidly delivering the necessary supplies. Rab10 acts a brake: Rab10 shunts supplies away from the neural connection and is turned off for more than 30 minutes to enhance the strengthening of neural connections. Broader impacts: As Rab10 gene variants are linked to resilience against Alzheimer’s Disease, these findings are critical to further research into strategies to protect memories in dementia. When we form a memory, specific, highly active connections between our neurons are strengthened through a process called synaptic potentiation. This strengthening involves structural changes to physically enlarge the connection and make it more responsive to incoming messages. Accomplishing this requires a complex logistical operation within the neuron to quickly and precisely deliver the necessary supplies to remodel the strengthening connection.

 

Cellular Railroad Switches

A large family of cellular switches, known as Rab proteins, regulates the flow of supplies in cells. Like railroad switches, different Rab proteins direct supplies toward one destination or another. To examine how these cellular switches direct supplies during synaptic potentiation, the researchers developed biosensors to measure the activity of Rab switches and specific supplies needed for strengthening neural connections.

“These biosensors give us a window into how these molecular switches behave in real time, at the level of single spines,” said Dr. Jie Wang, lead author of the study. “By understanding which and how Rab proteins are regulated during synaptic potentiation, we can begin to understand the logistical complexity that is required to strengthen neuronal connections when we form a memory.”

The scientists found that changes in Rab4 and Rab10 switches were both critical during the strengthening of neural connections. However, the two switches worked in opposite directions. When Rab4 was activated, it boosted the strengthening of neural connections, whereas Rab10 activation decreased it.

“Our findings suggest that during synaptic plasticity, we have a local and coordinated logistical operation to rapidly turn on Rab4 to increase the delivery of supplies to the surface of the growing connection and at the same time turn off the Rab10 switch that might be directing supplies away from the surface and toward disposal,” describes MPFI scientific Director and senior author Dr. Ryohei Yasuda.

To directly test this idea, the scientists tracked the delivery of neurotransmitter receptors, a crucial supply for strengthening neural connections. These receptors receive the information sent from connected neurons. The more receptors present, the easier a message is received. The team found that when Rab4 was activated, more receptors were directed to the neural connection. On the other hand, activation of Rab10 directed these receptors away from the connection.

 

Relevance to Alzheimer’s Resilience

These discoveries reveal the critical role of Rab cellular switches in strengthening connections during memory formation. Because gene variants in Rab10 have also been implicated in providing resilience against Alzheimer’s disease, the work may point toward new strategies for protecting memory in neurodegenerative conditions.

“I am excited about the potential for the tools and findings from this project, particularly for Rab10, to advance studies in Alzheimer’s resilience and Rab10 as a potential as a therapeutic target,” described Dr. Yasuda.  “Beyond that, we have created a library of tools that will help us, and other scientists, study the complex logistical operations essential for all cellular functions.”

Just as rail switches guide freight trains to the right track, more than 60 different Rab proteins direct cellular cargo. The Yasuda lab is sharing these biosensors to provide scientists a way to watch cellular logistics in action.

 

Publication:

Wang, J., Nishiyama, J., Parra-Bueno, P., Okaz, E., Oz, G., Liu, X., Watabe, T., Suponitsky-Kroyter, I., McGraw, T. E., Szatmari, E. M., & Yasuda, R. (2025). Rab10 inactivation promotes AMPAR trafficking and spine enlargement during long-term potentiation. eLife, 13, RP103879. 10.7554/eLife.10387910.7554/eLife.103879).

This work was supported by grants from Japan Society for the Promotion of Science Overseas Research Fellowship, National Institute of Health, a donation from the Luen Fung Group and the Max Planck Florida Institute for Neuroscience. This content is solely the authors’ responsibility and does not necessarily represent the official views of the funders.

END


ELSE PRESS RELEASES FROM THIS DATE:

Breast cancer startup founded by WashU Medicine researchers acquired by Lunit

2025-10-14
An innovative biotech startup founded by researchers at Washington University School of Medicine in St. Louis has been acquired by Lunit, a leading company in developing AI-based technologies for cancer prevention and early detection. The WashU startup, Prognosia, was created to develop software that harnesses AI to analyze mammograms and more accurately predict a woman’s five-year risk of developing breast cancer. The startup’s first software package, Prognosia Breast, received Breakthrough Device Designation from the Food and Drug Administration (FDA) earlier this year, ...

Breakthrough brain implant from NYU Abu Dhabi enables safer, more precise drug delivery

2025-10-14
Researchers at NYU Abu Dhabi (NYUAD) have developed a new type of brain implant that can deliver drugs to multiple regions of the brain with high precision, offering fresh possibilities for the treatment of neurological disorders. The device, called SPIRAL (Strategic Precision Infusion for Regional Administration of Liquid), is a thin, flexible tube designed to release medication at several points inside the brain. This approach allows doctors and scientists to reach larger and more complex areas of brain tissue than current tools, while still keeping the implant small and minimally invasive. ...

Combining non-invasive brain stimulation and robotic rehabilitation improves motor recovery in mouse stroke model

2025-10-14
Combining non-invasive brain stimulation and robotic rehabilitation improves motor recovery in mouse stroke model In your coverage, please use this URL to provide access to the freely available paper in PLOS Biology: https://plos.io/4gUkAy5    Article title: Combining gamma neuromodulation and robotic rehabilitation after a stroke restores parvalbumin interneuron dynamics and improves motor recovery in mice Author countries: Italy, Switzerland Funding: The study was funded by: Regione Toscana, PERSONA project, bando Salute 2018, https://www.regione.toscana.it/-/bando-ricerca-salute-2018, ...

Chickening out – why some birds fear novelty

2025-10-14
The largest-ever study on neophobia, or fear of novelty, has discovered the key reasons why some bird species are more fearful of new things than others. Published in the journal PLOS Biology, the global multi-species study was led by Dr Rachael Miller while at Anglia Ruskin University (ARU) and the University of Cambridge – with ARU funding the publication of the research – alongside a core leadership team from the ManyBirds Project. Neophobia plays a crucial role in how animals balance risk and opportunity. While caution can protect individuals from potential threats, it can also limit their ability to adapt to new nesting sites, foods ...

Gene Brown, MD, RPh, announced as President of the American Academy of Otolaryngology-Head and Neck Surgery and its Foundation

2025-10-14
October 14, 2025, Indianapolis, Indiana—Gene Brown, MD, RPh, became the President of the American Academy of Otolaryngology–Head and Neck Surgery and its Foundation (AAO-HNS/F) on October 14. He was elected by members of the AAO-HNS and will serve a one-year term leading the Academy's nearly 13,000 members who specialize in the treatment of the ears, nose, throat, and related structures of the head and neck. "Healthcare is changing rapidly and I'm honored to use this platform to keep our specialty’s focus on what matters most—supporting our members in their practices every day to ...

Study links wind-blown dust from receding Salton Sea to reduced lung function in area children

2025-10-14
Irvine, Calif., Oct. 14, 2025 – Children living near the Salton Sea, in Southern California’s desert region of Imperial County, are experiencing poorer lung function than children exposed to less wind-blown dust, according to a new study led by researchers at the University of California, Irvine’s Joe C. Wen School of Population & Public Health. They found that higher dust exposure – measured in hours per year – was linked to lower lung function, with the negative effects most pronounced among children living closest to the lake. The work, published in the American Journal of Respiratory and Critical Care Medicine, marks one of the ...

Multidisciplinary study finds estrogen could aid in therapies for progressive multiple sclerosis

2025-10-14
About 100,000 of the estimated million people in the United States with multiple sclerosis (MS) have a progressive form of the disease, with symptoms that worsen continuously or after periods of remission. “Progressive MS is profoundly challenging because it is relentless and treatment options are limited,” said Francisco P. Gomez, a neurologist who specializes in MS and neuroimmunology. MS is believed to occur when the immune system attacks the myelin sheath — the protective coating of the nerve fibers that transmit ...

Final day of scientific sessions reveals critical insights for clinical practice at AAO-HNSF Annual Meeting and OTO EXPO

2025-10-14
Indianapolis, Indiana – October 14, 2025 – The American Academy of Otolaryngology–Head and Neck Surgery Foundation (AAO-HNSF) 2025 Annual Meeting & OTO EXPO concluded its Scientific Oral Presentation program on Tuesday with 85 studies that establish new clinical correlations and provide evidence to optimize patient care across the full spectrum of otolaryngology practice. The final day's research program underscored the specialty's dedication to answering complex clinical questions ...

Social adversity and triple-negative breast cancer incidence among black women

2025-10-14
About The Study: This cohort study shows that high social adversity is associated with a high incidence of triple-negative breast cancer (TNBC) among Black women. As subtype is intrinsic to tumor development, these findings suggest an early and critical source of downstream breast cancer survival disparities. The findings of this study suggest potential social (epi)genomic and gene-environment interactions between social adversity and TNBC development in Black women. Corresponding author: To contact the corresponding author, Neha Goel, M.D., M.P.H., email goeln1@mskcc.org. To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/  (doi: ...

Rapid vs standard induction to injectable extended-release buprenorphine

2025-10-14
About The Study: In this multicenter randomized clinical trial, rapid induction had higher retention than standard induction overall and in patients who tested positive for fentanyl through extended-release buprenorphine injection 2. Administration of injection 2 after 1 week was well tolerated and minimized time below target therapeutic levels of 2 ng/mL or greater compared with injection after 1 month. Corresponding author: To contact the corresponding author, Robert L. Dobbins, M.D., Ph.D., email robert.dobbins@indivior.com. To ...

LAST 30 PRESS RELEASES:

Lower doses of immunotherapy for skin cancer give better results

Why didn’t the senior citizen cross the road? Slower crossings may help people with reduced mobility

ASH 2025: Study suggests that a virtual program focusing on diet and exercise can help reduce side effects of lymphoma treatment

A sound defense: Noisy pupae puff away potential predators

Azacitidine–venetoclax combination outperforms standard care in acute myeloid leukemia patients eligible for intensive chemotherapy

Adding epcoritamab to standard second-line therapy improves follicular lymphoma outcomes

New findings support a chemo-free approach for treating Ph+ ALL

Non-covalent btki pirtobrutinib shows promise as frontline therapy for CLL/SLL

University of Cincinnati experts present research at annual hematology event

ASH 2025: Antibody therapy eradicates traces of multiple myeloma in preliminary trial

ASH 2025: AI uncovers how DNA architecture failures trigger blood cancer

ASH 2025: New study shows that patients can safely receive stem cell transplants from mismatched, unrelated donors

Protective regimen allows successful stem cell transplant even without close genetic match between donor and recipient

Continuous and fixed-duration treatments result in similar outcomes for CLL

Measurable residual disease shows strong potential as an early indicator of survival in patients with acute myeloid leukemia

Chemotherapy and radiation are comparable as pre-transplant conditioning for patients with b-acute lymphoblastic leukemia who have no measurable residual disease

Roughly one-third of families with children being treated for leukemia struggle to pay living expenses

Quality improvement project results in increased screening and treatment for iron deficiency in pregnancy

IV iron improves survival, increases hemoglobin in hospitalized patients with iron-deficiency anemia and an acute infection

Black patients with acute myeloid leukemia are younger at diagnosis and experience poorer survival outcomes than White patients

Emergency departments fall short on delivering timely treatment for sickle cell pain

Study shows no clear evidence of harm from hydroxyurea use during pregnancy

Long-term outlook is positive for most after hematopoietic cell transplant for sickle cell disease

Study offers real-world data on commercial implementation of gene therapies for sickle cell disease and beta thalassemia

Early results suggest exa-cel gene therapy works well in children

NTIDE: Disability employment holds steady after data hiatus

Social lives of viruses affect antiviral resistance

Dose of psilocybin, dash of rabies point to treatment for depression

Helping health care providers navigate social, political, and legal barriers to patient care

Barrow Neurological Institute, University of Calgary study urges “major change” to migraine treatment in Emergency Departments

[Press-News.org] Cellular railroad switches: how brain cells route supplies to build memories